Tivic Health Systems, Inc. Stock

Equities

TIVC

US8887052095

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:30:00 2024-04-19 pm EDT 5-day change 1st Jan Change
1.11 USD -4.06% Intraday chart for Tivic Health Systems, Inc. -4.31% -38.33%
Sales 2022 1.84M Sales 2023 1.18M Capitalization 2.64M
Net income 2022 -10M Net income 2023 -8M EV / Sales 2022 1.74 x
Net cash position 2022 2.99M Net cash position 2023 3.03M EV / Sales 2023 -0.33 x
P/E ratio 2022
-0.61 x
P/E ratio 2023
-0.17 x
Employees 9
Yield 2022 *
-
Yield 2023
-
Free-Float 98.58%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Tivic Health Systems, Inc.

1 day-4.06%
1 week-4.31%
Current month-11.20%
1 month-11.90%
3 months-17.16%
6 months-12.61%
Current year-38.33%
More quotes
1 week
1.08
Extreme 1.08
1.22
1 month
1.08
Extreme 1.08
1.55
Current year
1.00
Extreme 1
2.24
1 year
1.00
Extreme 1
23.79
3 years
1.00
Extreme 1
650.00
5 years
1.00
Extreme 1
650.00
10 years
1.00
Extreme 1
650.00
More quotes
Managers TitleAgeSince
Founder 56 16-09-21
Director of Finance/CFO 52 23-04-27
Chief Tech/Sci/R&D Officer 40 19-02-28
Members of the board TitleAgeSince
Chairman 77 19-07-15
Director/Board Member 64 19-07-15
Founder 56 16-09-21
More insiders
Date Price Change Volume
24-04-19 1.11 -4.06% 14,603
24-04-18 1.157 +3.77% 4,792
24-04-17 1.115 +1.82% 13,880
24-04-16 1.095 -0.44% 11,411
24-04-15 1.1 -5.18% 22,739

Delayed Quote Nasdaq, April 19, 2024 at 04:30 pm EDT

More quotes
Tivic Health Systems, Inc. is a commercial-stage health tech company advancing the field of bioelectronic medicine. The Company’s patented technology platform leverages stimulation on the trigeminal, sympathetic, and vagus nerve structures. Its non-invasive and targeted approach to the treatment of inflammatory chronic health conditions is intended to give consumers and providers drug-free therapeutic solutions with high safety profiles, low risk, and broad applications. The Company’s first commercial product, ClearUP, is an FDA approved handheld bioelectronic sinus device. ClearUP is clinically proven, doctor-recommended, and available through online retailers and commercial distributors. ClearUP is sold in the U.S. directly to consumers on various platforms and through reseller channels. The Company is also focused on its intellectual property (IP) portfolio and research programs related to vagus nerve stimulation to expand its applications in non-invasive bioelectronic medicine.
More about the company

Quarterly revenue - Rate of surprise